07:59 AM EDT, 05/21/2025 (MT Newswires) -- Tango Therapeutics ( TNGX ) said Wednesday that the first patient has been dosed in its phase 1/2 trial to treat patients with methylthioadenosine phosphorylase-deleted solid tumors, with a focus on glioblastoma. TNG456 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor, the company said. People with GBM currently have few treatment options and a five-year...

07:57 AM EDT, 05/21/2025 (MT Newswires) -- NeurAxis (NRXS) said Wednesday that it has launched a registered direct offering for the purchase and sale of 1.5 million shares at $3.25 per share for gross proceeds of $5 million. The offering is expected to close on or about Thursday. NeurAxis said the net proceeds will be used for working capital and...

07:59 AM EDT, 05/21/2025 (MT Newswires) -- Shift4 Payments ( FOUR ) said Wednesday it has again extended its all-cash tender offer for all of the outstanding shares of Global Blue Group Holding ( GB ) . Global Blue's ( GB ) board has recommended that all shareholders tender their shares into the offer, which will remain open through one...

May 21 (Reuters) - Shift4 Payments Inc ( FOUR ): * SHIFT4 FURTHER EXTENDS PREVIOUSLY ANNOUNCED TENDER OFFER TO ACQUIRE GLOBAL BLUE Source text: Further company coverage: ...